Regulation of the human telomerase reverse transcriptase gene

被引:165
作者
Ducrest, AL [1 ]
Szutorisz, H [1 ]
Lingner, J [1 ]
Nabholz, M [1 ]
机构
[1] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland
关键词
telomerase; hTERT; regulation; transcription; repression; tumor;
D O I
10.1038/sj.onc.1205081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most somatic human cells lack telomerase activity because they do not express the telomerase reverse transcriptase (hTERT) gene. Conversely, most cancer cells express hTERT and are telomerase positive. For most tumors it is not clear whether hTERT expression is due to their origin from telomerase positive stem cells or to reactivation of the gene during tumorigenesis. Telomerase negative cells lack detectable cytoplasmic and nuclear hTERT transcripts; in telomerase positive cells 0.2 to 6 mRNA molecules/cell can be detected. This suggests that expression is regulated by changes in the rate of hTERT gene transcription. In tumor cell lines hTERT expression behaves like a recessive trait, indicating that lack of expression in normal cells is due to one or several repressors. Studies with monochromosomal hybrids indicate that several chromosomes may code for such repressors. A number of transcription factors, tumor suppressors, cell cycle inhibitors, cell fate determining molecules, hormone receptors and viral proteins have been implicated in the control of hTERT expression; but these studies have not yet provided a clear explanation for the tumor specific expression of the hTERT gene, and the cis-acting elements which are the targets of repression in normal cells still have to be identified.
引用
收藏
页码:541 / 552
页数:12
相关论文
共 116 条
[41]   cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome [J].
Horikawa, I ;
Barrett, JC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (15) :1171-1173
[42]  
Horikawa I, 1998, MOL CARCINOGEN, V22, P65, DOI 10.1002/(SICI)1098-2744(199806)22:2<65::AID-MC1>3.0.CO
[43]  
2-J
[44]  
Horikawa I, 1999, CANCER RES, V59, P826
[45]   Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang [J].
Huffman, KE ;
Levene, SD ;
Tesmer, VM ;
Shay, JW ;
Wright, WE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) :19719-19722
[46]   Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype [J].
Jiang, XR ;
Jimenez, G ;
Chang, E ;
Frolkis, M ;
Kusler, B ;
Sage, M ;
Beeche, M ;
Bodnar, AG ;
Wahl, GM ;
Tlsty, TD ;
Chiu, CP .
NATURE GENETICS, 1999, 21 (01) :111-114
[47]  
Kanaya T, 2000, CLIN CANCER RES, V6, P1239
[48]   Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit [J].
Kang, SS ;
Kwon, T ;
Kwon, DY ;
Do, SI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13085-13090
[49]   Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase [J].
Kharbanda, S ;
Kumar, V ;
Dhar, S ;
Pandey, P ;
Chen, C ;
Majumder, P ;
Yuan, ZM ;
Whang, Y ;
Strauss, W ;
Pandita, TK ;
Weaver, D ;
Kufe, D .
CURRENT BIOLOGY, 2000, 10 (10) :568-575
[50]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015